These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Low Grade Micropapillary Urothelial Carcinoma, Does It Exist? - Analysis of Management and Outcomes from the Surveillance, Epidemiology and End Results (SEER) Database. Vourganti S; Harbin A; Singer EA; Shuch B; Metwalli AR; Agarwal PK J Cancer; 2013; 4(4):336-42. PubMed ID: 23678370 [TBL] [Abstract][Full Text] [Related]
6. Micropapillary bladder cancer: a clinico-pathological characterization and treatment analysis. Li Z; Liao H; Tan Z; Mao D; Wu Y; Xiao YM; Yang SK; Zhong L Clin Transl Oncol; 2017 Oct; 19(10):1217-1224. PubMed ID: 28432572 [TBL] [Abstract][Full Text] [Related]
7. The Natural History, Treatment Pattern, and Outcomes of Patients With Micropapillary Bladder Carcinoma. Wang J; Wang FW Am J Clin Oncol; 2015 Oct; 38(5):472-8. PubMed ID: 24064750 [TBL] [Abstract][Full Text] [Related]
8. Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer. Hermans TJN; Voskuilen CS; Deelen M; Mertens LS; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; Pos FJ; de Wit R; Beerepoot LV; Verhoeven RHA; van Rhijn BWG Int J Cancer; 2019 Mar; 144(6):1453-1459. PubMed ID: 30155893 [TBL] [Abstract][Full Text] [Related]
14. Micropapillary Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of Disease Characteristics and Treatment Outcomes. Abufaraj M; Foerster B; Schernhammer E; Moschini M; Kimura S; Hassler MR; Preston MA; Karakiewicz PI; Remzi M; Shariat SF Eur Urol; 2019 Apr; 75(4):649-658. PubMed ID: 30553613 [TBL] [Abstract][Full Text] [Related]
15. Contemporary treatment patterns and outcomes of sarcomatoid bladder cancer. Sui W; Matulay JT; Onyeji IC; Theofanides MC; James MB; RoyChoudhury A; Wenske S; DeCastro GJ World J Urol; 2017 Jul; 35(7):1055-1061. PubMed ID: 27803966 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder. Ghoneim IA; Miocinovic R; Stephenson AJ; Garcia JA; Gong MC; Campbell SC; Hansel DE; Fergany AF Urology; 2011 Apr; 77(4):867-70. PubMed ID: 21296399 [TBL] [Abstract][Full Text] [Related]
17. Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer. Meeks JJ; Taylor JM; Matsushita K; Herr HW; Donat SM; Bochner BH; Dalbagni G BJU Int; 2013 Jun; 111(8):E325-30. PubMed ID: 23384236 [TBL] [Abstract][Full Text] [Related]
18. Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation. Mitra AP; Fairey AS; Skinner EC; Boorjian SA; Frank I; Schoenberg MP; Bivalacqua TJ; Hyndman ME; Reese AC; Steinberg GD; Large MC; Hulsbergen-van de Kaa CA; Bruins HM; Daneshmand S Urol Oncol; 2019 Jan; 37(1):48-56. PubMed ID: 30446450 [TBL] [Abstract][Full Text] [Related]
19. A delay ≥8 weeks to neoadjuvant chemotherapy before radical cystectomy increases the risk of upstaging. Audenet F; Sfakianos JP; Waingankar N; Ruel NH; Galsky MD; Yuh BE; Gin GE Urol Oncol; 2019 Feb; 37(2):116-122. PubMed ID: 30509868 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA. Hanna N; Trinh QD; Seisen T; Vetterlein MW; Sammon J; Preston MA; Lipsitz SR; Bellmunt J; Menon M; Choueiri TK; Abdollah F Eur Urol Oncol; 2018 May; 1(1):83-90. PubMed ID: 31100232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]